Non-promoter Snehjeev Ventures crosses 9% stake in Amerise Biosciences via open market

Creeping Acquisition Near ThresholdOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.80

prior close

₹0.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.9%-1.9% vs market

Plastic Products - Industrial peers, median of 38sector+0.8%-0.8% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 0.8 pts less than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+1.9-1.9+0.8-0.8

Next day

+5.0+3.3+1.7+1.8+3.2

+10.0+3.5+6.5+1.6+8.4

+15.0+2.4+12.6+1.0+14.0

+18.8+3.1+15.7+1.3+17.5

+16.3+2.6+13.6+1.8+14.5

+10.0+2.1+7.9+2.1+7.9

15d

+26.3+0.9+25.3+1.0+25.3

+7.5+5.5+2.0+1.1+6.4

+7.5+8.1-0.6+6.4+1.1

+0.0+3.5-3.5-0.4+0.4

UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 38Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Snehjeev Ventures Pvt Ltd along with PACs (Lunkad family members) acquired 38,574 equity shares (0.06%) of Amerise Biosciences through the open market on 6 July 2026. Holding rose from 8.98 percent (59.33 lakh shares) to 9.04 percent (59.72 lakh shares). The acquirer is not part of the promoter or promoter group. Total share capital is 66.06 lakh equity shares of Rs 10 each. Disclosure filed under SEBI SAST Regulation 29(2).

Likely market impact

Non-promoter creeping buy approaching 10 percent threshold. Further acquisitions beyond 10 percent would trigger additional SEBI disclosures and takeover code implications.